Log in

Relevant bibliographies by topics / Leukemia Lymphomas T cells

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Leukemia Lymphomas T cells'

Author: Grafiati

Published: 4 June 2021

Last updated: 10 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Leukemia Lymphomas T cells.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Leukemia Lymphomas T cells"

1

Bollard, Catherine M., and A. John Barrett. "Cytotoxic T lymphocytes for leukemia and lymphoma." Hematology 2014, no. 1 (2014): 565–69. http://dx.doi.org/10.1182/asheducation-2014.1.565.

Full text

Abstract:

Abstract This chapter focuses on the recent advances in adoptive T-cell immunotherapies, not only for patients after hematopoietic stem cell transplantation, but also in the autologous setting using T cells early in the disease process for the treatment of the highest-risk patients with leukemias and lymphomas. The particular emphasis is to highlight the role of T-cell therapies for hematologic malignancies using a non-gene-transfer approach to direct specificity, including the clinical use of T-cell therapies for EBV-associated lymphomas and strategies for targeting nonviral lymphoma- and leu

APA, Harvard, Vancouver, ISO, and other styles

2

Singh, Anju, Anne Flörcken, Antje van Lessen, Bernd Dörken, Antonio Pezzutto, and Jörg Westermann. "CD3-Negative CD4+ T-Cells: A Useful Diagnostic Tool with High Specificity in Angioimmunoblastic Lymphadenopathy (AILD)-Type T-Cell Lymphoma." Blood 112, no. 11 (2008): 5311. http://dx.doi.org/10.1182/blood.v112.11.5311.5311.

Full text

Abstract:

Abstract Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma is one of the common T cell lymphomas in Western countries. Many patients present with symptoms of a systemic disease and diagnosis can often be challenging. Particularly in cases in which histological confirmation cannot be easily achieved flowcytometry of peripheral blood can give important clues for the differential diagnosis of AILD. We have previously reported that CD4-negative CD3+ T-cells in peripheral blood are a characteristic immunophenotypic finding in AILD patients. Gene scan analysis for the TCR gamma chain an

APA, Harvard, Vancouver, ISO, and other styles

3

Shi, Yang, and Endi Wang. "Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic Review." Archives of Pathology & Laboratory Medicine 138, no. 4 (2014): 564–69. http://dx.doi.org/10.5858/arpa.2013-0101-rs.

Full text

Abstract:

Blastic plasmacytoid dendritic cell neoplasm is a rare entity grouped with the acute myeloid leukemia–related precursor neoplasms in the 2008 World Health Organization classification. It was previously postulated to originate from natural killer cells, T cells, or monocytes but is now believed to arise from the plasmacytoid dendritic cell. The pathogenesis of blastic plasmacytoid dendritic cell neoplasm is not well understood, although the neoplasm demonstrates frequent deletion of tumor suppressor genes, including RB1, CDKN1B, CDKN2A, and TP53. Blastic plasmacytoid dendritic cell neoplasm is

APA, Harvard, Vancouver, ISO, and other styles

4

Rosolen, A., M. Nakanishi, DG Poplack, et al. "Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies." Blood 73, no. 7 (1989): 1968–72. http://dx.doi.org/10.1182/blood.v73.7.1968.1968.

Full text

Abstract:

Abstract The expression of the interleukin-2 (IL-2) receptor was studied in neoplastic cells derived from acute leukemias, T-cell lymphoblastic lymphomas, peripheral T-cell lymphomas, chronic lymphocytic leukemias, well-differentiated lymphocytic lymphomas, and established cell lines by both flow cytometric analysis and sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) after affinity crosslinking of radiolabeled IL-2. Cells from most acute leukemias (19 of 22), irrespective of their subtype (T, common or nonlymphoid leukemias), as well as T-cell lymphoblastic lymphomas and p

APA, Harvard, Vancouver, ISO, and other styles

5

Rosolen, A., M. Nakanishi, DG Poplack, et al. "Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies." Blood 73, no. 7 (1989): 1968–72. http://dx.doi.org/10.1182/blood.v73.7.1968.bloodjournal7371968.

Full text

Abstract:

The expression of the interleukin-2 (IL-2) receptor was studied in neoplastic cells derived from acute leukemias, T-cell lymphoblastic lymphomas, peripheral T-cell lymphomas, chronic lymphocytic leukemias, well-differentiated lymphocytic lymphomas, and established cell lines by both flow cytometric analysis and sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) after affinity crosslinking of radiolabeled IL-2. Cells from most acute leukemias (19 of 22), irrespective of their subtype (T, common or nonlymphoid leukemias), as well as T-cell lymphoblastic lymphomas and peripheral

APA, Harvard, Vancouver, ISO, and other styles

6

Hsieh, Emily M., and Rayne H. Rouce. "Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphoma." Hematology 2020, no. 1 (2020): 487–93. http://dx.doi.org/10.1182/hematology.2020000133.

Full text

Abstract:

Abstract Chimeric antigen receptor (CAR) T-cell therapy has changed the landscape of immunotherapy for B-cell malignancies, including mature B-cell lymphomas. Although two CD19 CAR T-cell products have been commercially approved to treat relapsed/refractory B-cell lymphomas, outcomes in these patients remain inferior to those of patients with B-cell leukemia, regardless of therapy. Recent clinical studies and preclinical reports suggest that certain characteristics, such as the suppressive lymphoma tumor microenvironment and inferior endogenous T-cell fitness, may contribute to discrepant resp

APA, Harvard, Vancouver, ISO, and other styles

7

Schwarzinger, Ilse, Markus Exner, Harald Esterbauer, et al. "Microvessel Endothelial Cells of Hematological Malignancies Harbor Disease Specific Genetic Aberrations." Blood 104, no. 11 (2004): 544. http://dx.doi.org/10.1182/blood.v104.11.544.544.

Full text

Abstract:

Abstract The growth of most tumors depends on the formation of new blood vessels. In contrast to genetically unstable tumor cells, endothelial cells of tumor vessels are believed to be normal diploid cells that do not acquire mutations. We have recently observed that microvessel endothelial cells of patients with B-cell lymphomas carry lymphoma specific aberrations (NEJM351:250–9, 2004). The aim of this study was to determine whether hematological malignancies other than B-cell lymphomas also carry disease specific genetic aberrations. Using a combined immunohistochemical and fluorescence in s

APA, Harvard, Vancouver, ISO, and other styles

8

Jang, Min Soo, Dong Young Kang, Jong Bin Park, Sang Tae Kim, and Kee Suck Suh. "Cutaneous T-Cell Lymphoma in Asians." ISRN Dermatology 2012 (July 15, 2012): 1–8. http://dx.doi.org/10.5402/2012/575120.

Full text

Abstract:

Cutaneous T-cell lymphoma describes a heterogeneous group of neoplasms of skin homing T cells that vary considerably in clinical presentation, histologic appearance, immunophenotype, and prognosis. This paper addresses the cutaneous T-cell lymphoma in Asians with respect to clinical-epidemiologic and histopathological features. Compared with Western countries, Asia usually has higher rates of cutaneous T-cell lymphomas such as extranodal NK/T-cell lymphoma, hydroa vacciniforme-like lymphoma, subcutaneous panniculitis T-cell lymphoma, and adult T-cell leukemia/lymphoma and lower rates of cutane

APA, Harvard, Vancouver, ISO, and other styles

9

Lança, Telma, Daniel V. Correia, Catarina F. Moita та ін. "The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity". Blood 115, № 12 (2010): 2407–11. http://dx.doi.org/10.1182/blood-2009-08-237123.

Full text

Abstract:

Abstract On the path to successful immunotherapy of hematopoietic tumors, γδ T cells offer great promise because of their human leukocyte antigen (HLA)–unrestricted targeting of a wide variety of leukemias/lymphomas. However, the molecular mechanisms underlying lymphoma recognition by γδ T cells remain unclear. Here we show that the expression levels of UL16-binding protein 1 (ULBP1) determine lymphoma susceptibility to γδ T cell–mediated cytolysis. Consistent with this, blockade of NKG2D, the receptor for ULBP1 expressed on all Vγ9+ T cells, significantly inhibits lymphoma cell killing. Speci

APA, Harvard, Vancouver, ISO, and other styles

10

Moffitt, Andrea B., and Sandeep S. Dave. "Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma." Journal of Clinical Oncology 35, no. 9 (2017): 955–62. http://dx.doi.org/10.1200/jco.2016.71.7603.

Full text

Abstract:

In this review, we examine the genomic landscapes of lymphomas that arise from B, T, and natural killer cells. Lymphomas represent a striking spectrum of clinical behaviors. Although some lymphomas are curable with standard therapy, the majority of the affected patients succumb to their disease. Here, the genetic underpinnings of these heterogeneous entities are reviewed. We consider B-cell lymphomas, including Burkitt lymphoma, diffuse large B-cell lymphoma, Hodgkin lymphoma, and primary mediastinal B-cell lymphoma. We also examine T-cell lymphomas, including anaplastic large-cell lymphoma, a

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Leukemia Lymphomas T cells"

1

Chan, Wai. "Clonal rearrangement of T-cell receptor delta gene in hematological malignancies and applications in detection of minimal residual disease /." Hong Kong : University of Hong Kong, 1995. http://sunzi.lib.hku.hk/hkuto/record.jsp?B1705512X.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

陳衛 and Wai Chan. "Clonal rearrangement of T-cell receptor delta gene in hematological malignancies and applications in detection of minimal residualdisease." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1995. http://hub.hku.hk/bib/B31212852.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rezanka, Louis J. "cDNA cloning and analysis of the feline T-cell receptor beta gene (TCR-[beta]) with special reference to feline leukemia virus-associated lymphomas /." The Ohio State University, 1991. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487687485810901.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pfeilschifter, Janina Marie. "Targeting B non-Hodgkin lymphoma and tumor-supportive follicular helper T cells with anti-CXCR5 CAR T cells." Doctoral thesis, Humboldt-Universität zu Berlin, 2021. http://dx.doi.org/10.18452/23169.

Full text

Abstract:

CAR-T-Zell-Therapie ist eine vielversprechende neuartige Behandlungsform für Patienten mit aggressiven B-Zell Non-Hodgkin-Lymphomen (B-NHL). In dieser Arbeit wurde die anti-CXCR5 CAR-T-Zell-Therapie als Alternative zur anti-CD19 CAR-T-Zell-Therapie für die Behandlung von reifen B-NHLs untersucht. CXCR5 ist ein B-Zell-homing Rezeptor, der von reifen B Zellen und follikulären T-Helferzellen (TFH Zellen) exprimiert wird. TFH Zellen wurden als tumor-unterstützend in chronisch lymphatischer Leukämie (CLL) und im follikulären Lymphom (FL) beschrieben. Dieses Expressionsmuster erlaubt es, auf einziga

APA, Harvard, Vancouver, ISO, and other styles

5

Mohamed, Mahgoub Mohamed Ahmed Mohamed. "Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells." Kyoto University, 2018. http://hdl.handle.net/2433/232139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nicoletti, Simon. "Natural Killer Cells and Pre-B Acute Lymphoblastic Leukemia : Evidence for an Unconventional Cytotoxicity Pathway." Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLS383.

Full text

Abstract:

Les cellules Natural Killer (NK) représentent une population de cellules innées lymphoïdes aux fonctions anti-infectieuses et antitumorales. Les leucémies aiguës lymphoblastiques pré-B (LAL pré-B) constituent le cancer de l’enfant le plus fréquent et ont été décrites comme résistantes à la cytotoxicité médiée par les NK bien que les bases moléculaires demeurent inconnues.L’objectif de ces travaux a été de caractériser cette résistance. En développant un essai de cytotoxicité par cytométrie en flux et en utilisant des cellules effectrices activées in vitro, nous avons établi la sensibilité reta

APA, Harvard, Vancouver, ISO, and other styles

7

Catherinet, Claire. "Etude des effecteurs de la voie Ca2+/Calmoduline dans les leucémies aiguës lymphoblastiques T." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCC293/document.

Full text

Abstract:

Les leucémies aigües lymphobastiques (LAL) représentent un tiers des leucémies et constituent le cancer pédiatrique le plus fréquent chez l’enfant. Les LAL de type T (LAL-T)sont caractérisées par l’expansion anormale de progéniteurs de lymphocytes T. Aujourd’hui,la réponse curative aux traitements est proche de 80% chez l’enfant et 50% chez l’adulte. La rechute reste donc fréquente et souvent de mauvais pronostic. Pour ces raisons,l’identification de nouvelles voies de signalisation en vue de développer de nouvelles stratégies thérapeutiques est cruciale afin d’améliorer le traitement des LAL-

APA, Harvard, Vancouver, ISO, and other styles

8

Meireles, Ana Luísa Langanke Pedroso. "Quantificação de células endoteliais circulantes em portadores assintomáticos do vírus linfotrópico humano de células T do tipo 1 (HTLV1) por citometria de fluxo." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5167/tde-09062009-170516/.

Full text

Abstract:

Células endoteliais provenientes da medula óssea (MO) participam da fisiopatologia de várias doenças que possuem dano vascular como fator em comum. Apesar de consideradas evento raro, encontram-se em quantidade aumentada na circulação periférica de pacientes oncológicos. Evidências sugerem que células endoteliais progenitoras (CEPs) contribuem para a angiogênese tumoral. Com esta descoberta, CEPs e células endoteliais maduras (CEMs) vêm sendo estudadas como potenciais alvos terapêuticos com o uso de drogas anti-angiogênicas. Portadores do vírus linfotrópico humano de células T do tipo 1 (HTLV1

APA, Harvard, Vancouver, ISO, and other styles

9

Johansson, Ann-Sofie. "Establishment and characterization of a murine T-cell lymphoma/leukemia model." Doctoral thesis, Umeå universitet, Institutionen för strålningsvetenskaper, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-35195.

Full text

Abstract:

Mouse models of human disease are valuable tools for studying pathogenesis and for evaluating novel therapies. T-cell lymphoma is a relatively rare disease in humans, affecting 100-150 persons yearly in Sweden. It exists in both aggressive and more indolent forms. We have established a mouse model for an aggressive T-cell lymphoma, the T-cell lymphoma/leukemia (TLL) mouse. In the present thesis, the TLL mouse model was characterized and used for experimental therapeutic and primary prevention studies. The TLL mouse was established unintentionally in our laboratory during work on VH-gene replac

APA, Harvard, Vancouver, ISO, and other styles

10

Kohart, Nicole Ann Kohart. "Models, Mechanisms, and Treatment of Adult T-cell Leukemia/Lymphoma Bone Metastasis." The Ohio State University, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=osu1503248777003095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Leukemia Lymphomas T cells"

1

Kenton, Charlotte. Human T-cell leukemia/lymphoma virus (HTLV), January 1982 through September 1984, 234 citations. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Symposium, Takamatsu no Miya Hi Gan Kenkyū Kikin International. Retroviruses in human lymphoma/leukemia: Proceedings of the 15th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1984. Japan Scientific Societies Press, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Watanabe, Toshiki, and Takuya Fukushima, eds. Adult T-cell Leukemia/Lymphoma. Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-56523-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ramahi, Tarik Mustafa. The rearrangement of the immunoglobulin and T-cell receptor genes in chronic myelogenous leukemia /by Tarik Mustafa Ramahi. s.n.], 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Aswald, Jorg M. Intracellular cytokine analysis in T-cells of patients with chronic myeloid leukemia. National Library of Canada, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Essex, Myron. Selected abstracts on viral etiology of human cancer.: Human T-cell leukemia viruses. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Blood cancers: Hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Seventh Congress, first session, special hearing, June 21, 2001, Washington, DC. U.S. G.P.O., 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mar, Pearl. Analysis of clonality and lineage of leukemic cell populations and monitoring of bone marrow transplantation using in situ hybridization and blotting methods. GSF-Forschungzentrum für Umwelt Und Gesundheit, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bone marrow diagnosis in clinical practice. Johns Hopkins University Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cerhan, James R., Claire M. Vajdic, and John J. Spinelli. The Non-Hodgkin Lymphomas. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0040.

Full text

Abstract:

The non-Hodgkin lymphomas (NHL) are a heterogeneous group of over forty lymphoid neoplasms that have undergone a major redefinition over the last twenty-five years, in part due to advances in immunology and genetics as well as implementation of the WHO classification system. NHLs are considered clonal tumors of B-cells, T-cells, or natural killer (NK) cells arrested at various stages of differentiation, regardless of whether they present in the blood (lymphoid leukemia) or lymphoid tissues (lymphoma). In the United States, the age-standardized NHL incidence rate (per 100,000) doubled from 1973

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Leukemia Lymphomas T cells"

1

Flaig, M. J., and C. A. Sander. "Adult T-cell lymphoma/leukemia." In Cutaneous Lymphomas. Steinkopff, 2001. http://dx.doi.org/10.1007/978-3-642-57624-9_43.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Tsukasaki, Kunihiro, and Kensei Tobinai. "Adult T-cell Leukemia-Lymphoma." In Rare Lymphomas. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-39590-1_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ott, German, Eric D. Hsi, John F. Seymour, and Georg Hopfinger. "B-Cell Prolymphocytic Leukemia (B-PLL) and T-Cell Prolymphocytic Leukemia (T-PLL)." In Rare Lymphomas. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-39590-1_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Goyal, Amrita, Joi B. Carter, and Lyn McDivitt Duncan. "Adult T-Cell Leukemia/Lymphoma." In Atlas of Cutaneous Lymphomas. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17217-0_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Quint, K. D., R. Willemze, and M. H. Vermeer. "Case 49. Adult T-cell leukemia/lymphoma." In Cutaneous Lymphomas. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-59129-8_49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Malpica Castillo, Luis, and Christopher Dittus. "Adult T-Cell Leukemia/Lymphoma." In Novel Therapeutics for Rare Lymphomas. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25610-4_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Watanabe, Toshiki. "Leukemogenesis and Molecular Characteristics of Tumor Cells." In Adult T-cell Leukemia/Lymphoma. Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-56523-9_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Iwatsuki, K. "A cutaneous variant of adult T-cell leukemia mimicking pityriasis lichenoides et varioliformis acuta (PLEVA)." In Cutaneous Lymphomas. Steinkopff, 2001. http://dx.doi.org/10.1007/978-3-642-57624-9_44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Dimitriou, F., M. C. Brüggen, and E. Guenova. "Case 36. Primary cutaneous aggressive epidermotropic T-cell lymphoma as a composite lymphoma with B-cell chronic lymphocytic leukemia." In Cutaneous Lymphomas. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-59129-8_36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bougrine, A., C. B. Hergott, O. K. Weinberg, D. C. Fisher, and C. Larocca. "Case 50. A relapse of T-cell large granular lymphocytic (LGL) leukemia with chronic NK lymphocytosis in the skin." In Cutaneous Lymphomas. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-59129-8_50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Leukemia Lymphomas T cells"

1

Sanchez-Hidalgo, Marina, Melanie Lee, Catalina Alarcón de la Lastra, Juan M. Guerrero, and Graham Packham. "Abstract 3662: Melatonin inhibits cell proliferation and induces apoptosis in human acute leukemia T and lymphoma B cells via a receptor independent mechanism." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3662.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Enblad, Gunilla, Hannah Karlsson, Kristina I. Wikstrom, et al. "Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-a041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lee, Daniel W., Nirali Shah, Maryalice Stetler-Stevenson, et al. "Abstract LB-138: Autologous-collected anti-cd19 chimeric antigen receptor (CAR) T cells for acute lymphocytic leukemia (ALL) and Non-Hodgkin's lymphoma (NHL) in children who have previously undergone allogeneic hematopoietic stem cell transplantation (HSCT)." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-lb-138.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Benninghoff, Abby D., Amanda M. Hagman, Lyndsey E. Shorey, and David E. Williams. "Abstract 5441: Anticancer effects of 3,3′-diindolylmethane (DIM) in multiple T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) cell lines." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Khan, Hamidullah, Sushmita Roy, Ashish Anshu, Wasakorn Kittipongdaja, and Stefan M. Schieke. "Abstract 2178: Single cell dynamics maintain an intrinsic drug resistant state in T cell leukemia and lymphoma." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-2178.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nakagawa, Masao, Roland Schmitz, Wenming Xiao, et al. "Abstract 3936: Frequent gain-of-function CCR4 mutations in adult T-cell leukemia/lymphoma (ATLL)." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3936.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Alahapperuma, Thushari, James N. Mubiru, Alice Yang, et al. "Abstract 82: Development of the baboon as an animal model for adult T-cell leukemia/lymphoma." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-82.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nagata, Yasunobu, Yusuke Okuno, Aiko Sato, et al. "Abstract 2019: Whole exome analysis reveals spectrum of gene mutations in adult T-cell leukemia/lymphoma." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Neubauer, Heidi A., Tobias Suske, Susann Schönefeldt, et al. "Abstract 2752: The gain-of-function STAT5BN642Hmutation as a driver of mature T cell leukemia/lymphoma." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Karnik, Sushant, Minh Thu Pham, Pooja Keerthipati, et al. "Abstract 6595: Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-6595.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Leukemia Lymphomas T cells"

1

Cooper, Laurence, and Rita Young. Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor-Cell Transplant. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada487262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cooper, Laurence. Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor-Cell Transplant. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada560655.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!